660 — Wai Chun Bio Technology Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapNeutral

Annual balance sheet for Wai Chun Bio Technology, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.

	2020 December 31st	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	5.45	7.52	6.31	2.16	6.56
Net Total Accounts Receivable
Net Total Receivables	14.1	50.8	42.4	52.2	28.8
Total Inventory
Total Other Current Assets
Total Current Assets	90.2	153	129	114	107
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	98.1	97.2	111	80.7	93.2
Other Long Term Assets
Total Assets	188	250	240	209	215
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	150	178	159	254	277
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	226	288	275	289	306
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-37.5	-37.7	-35	-79.3	-91.1
Total Liabilities & Shareholders' Equity	188	250	240	209	215
Total Common Shares Outstanding
Total Preferred Shares Outstanding